Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients.
Wachter DL, Fasching PA, Haeberle L, Schulz-Wendtland R, Dimmler A, Koscheck T, Renner SP, Lux MP, Beckmann MW, Hartmann A, Rauh C, Schrauder MG.
Wachter DL, et al. Among authors: koscheck t.
Arch Gynecol Obstet. 2013 Feb;287(2):337-44. doi: 10.1007/s00404-012-2534-9. Epub 2012 Sep 6.
Arch Gynecol Obstet. 2013.
PMID: 22955249